{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:42:09Z","timestamp":1792525329463,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11892-019-1166-x","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T06:03:19Z","timestamp":1562220199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Bioprinting an Artificial Pancreas for Type 1 Diabetes"],"prefix":"10.1007","volume":"19","author":[{"given":"Juewan","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungwon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Drogemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon G.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Toby","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"1166_CR1","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/B978-1-4377-1604-7.00561-3","volume-title":"Goldman's Cecil Medicine","author":"Silvio E. Inzucchi","year":"2012","unstructured":"Gregory JM, Moore DJ. Type 1 diabetes mellitus. Pediatr Rev 2013. \n                      https:\/\/doi.org\/10.1016\/B978-1-4377-1604-7.00561-3\n                      \n                    ."},{"key":"1166_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1383\/medc.2006.34.2.57","volume":"42","author":"NG Forouhi","year":"2014","unstructured":"Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Baltimore). 2014;42:698\u2013702. \n                      https:\/\/doi.org\/10.1383\/medc.2006.34.2.57\n                      \n                    .","journal-title":"Medicine (Baltimore)"},{"key":"1166_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2337\/dc13-S067","volume":"36","author":"DOF Diabetes","year":"2013","unstructured":"Diabetes DOF. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:67\u201374. \n                      https:\/\/doi.org\/10.2337\/dc13-S067\n                      \n                    .","journal-title":"Diabetes Care"},{"key":"1166_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2337\/db14-0858","volume":"64","author":"V Pathiraja","year":"2015","unstructured":"Pathiraja V, Kuehlich JP, Campbell PD, Krishnamurthy B, Loudovaris T, Coates PTH, et al. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes. Diabetes. 2015;64:172\u201382. \n                      https:\/\/doi.org\/10.2337\/db14-0858\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32:1121\u201333. \n                      https:\/\/doi.org\/10.1038\/nbt.3033\n                      \n                    .","journal-title":"Nat Biotechnol"},{"key":"1166_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3727\/096368911X612530","volume":"21","author":"KR Prabakar","year":"2012","unstructured":"Prabakar KR, Dom\u00ednguez-Bendala J, Damaris Molano R, Pileggi A, Villate S, Ricordi C, et al. Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Cell Transplant. 2012;21:1321\u201339. \n                      https:\/\/doi.org\/10.3727\/096368911X612530\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1055\/s-0032-1312569","volume":"29","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, Brayman KL. Update on islet cell transplantation for type 1 diabetes. Semin Interv Radiol. 2012;29:90\u20138. \n                      https:\/\/doi.org\/10.1055\/s-0032-1312569\n                      \n                    .","journal-title":"Semin Interv Radiol"},{"key":"1166_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2337\/diacare.29.04.06.dc06-9908.","volume":"29","author":"RP Robertson","year":"2006","unstructured":"Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DER, American Diabetes Association. Pancreas and islet transplantation in type 1 diabetes. Diabetes Care. 2006;29:935. \n                      https:\/\/doi.org\/10.2337\/diacare.29.04.06.dc06-9908.","journal-title":"Diabetes Care"},{"issue":"1","key":"1166_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.12809\/hkmj154613","volume":"22","author":"C Chan","year":"2016","unstructured":"Chan C, Chim TM, Leung K, Tong C, Wong T, Leung GK. Simultaneous pancreas and kidney transplantation as the standard surgical treatment for diabetes mellitus patients with end-stage renal disease. Hong Kong Med J. 2016;22(1):62\u20139. \n                      https:\/\/doi.org\/10.12809\/hkmj154613\n                      \n                    .","journal-title":"Hong Kong Med J"},{"key":"1166_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MOT.0b013e3283355349","volume":"15","author":"C Troppmann","year":"2010","unstructured":"Troppmann C. Complications after pancreas transplantation. Curr Opin Organ Transpl. 2010;15:112\u20138. \n                      https:\/\/doi.org\/10.1097\/MOT.0b013e3283355349\n                      \n                    .","journal-title":"Curr Opin Organ Transpl"},{"key":"1166_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MOT.0b013e32833553f8","volume":"15","author":"M Vardanyan","year":"2010","unstructured":"Vardanyan M, Parkin E, Gruessner C, Rilo HLR. Pancreas vs. islet transplantation: a call on the future. Curr Opin Organ Transplant. 2010;15:124\u201330. \n                      https:\/\/doi.org\/10.1097\/MOT.0b013e32833553f8\n                      \n                    .","journal-title":"Curr Opin Organ Transplant"},{"key":"1166_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJMra032425","volume":"350","author":"RP Robertson","year":"2004","unstructured":"Robertson RP. Islet transplantation as a treatment for diabetes \u2014 a work in progress. N Engl J Med. 2004;350:694\u2013705. \n                      https:\/\/doi.org\/10.1056\/NEJMra032425\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"1166_CR13","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ajt.12250","volume":"13","author":"PJO Connell","year":"2013","unstructured":"Connell PJO, Holmes-Walker DJ, Goodman D, Hawthorne WJ, Loudovaris T, Gunton JE, et al. Multicenter Australian trial of islet transplantation: improving accessibility and outcomes. Am J Transplant. 2013;13:1850\u20138. \n                      https:\/\/doi.org\/10.1002\/ajt.12250\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"1166_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00534-008-0021-2.Current","volume":"16","author":"H Ichii","year":"2013","unstructured":"Ichii H, Ricordi C. Current status of islet cell transplantation. J Hepato-Biliary-Pancreat Surg. 2013;16:101\u201312. \n                      https:\/\/doi.org\/10.1007\/s00534-008-0021-2.Current\n                      \n                    .","journal-title":"J Hepato-Biliary-Pancreat Surg"},{"key":"1166_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2337\/diab.21.10.987","volume":"21","author":"PE Lacy","year":"1972","unstructured":"Lacy PE, Walker MM, Fink CJ, Louis S. Perifusion of isolated rat islets in vitro participation of the microtubular system in the biphasic release of insulin. Diabetes. 1972;21:987\u201398. \n                      https:\/\/doi.org\/10.2337\/diab.21.10.987\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR16","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/00000658-198010000-00011","volume":"192","author":"JS Najarian","year":"1980","unstructured":"Najarian JS, Sutherland DER, Baumgartner D, Burke B, Rynasiewicz JJ, Matas AJ, et al. Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.pdf. Ann Surg. 1980;192:526\u201342.","journal-title":"Ann Surg"},{"key":"1166_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2337\/diabetes.50.1.47","volume":"50","author":"RP Robertson","year":"2001","unstructured":"Robertson RP, Lanz KJ, Sutherland DER, Kendall DM. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis. Diabetes. 2001;50:48\u201350. \n                      https:\/\/doi.org\/10.2337\/diabetes.50.1.47\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AMJ Shapiro","year":"2000","unstructured":"Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocoricoid-free imunosuppressive regimen. N Engl J Med. 2000;343:230\u20138. \n                      https:\/\/doi.org\/10.1056\/NEJM200007273430401\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"1166_CR19","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","volume":"54","author":"EA Ryan","year":"2005","unstructured":"Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060\u20139.","journal-title":"Diabetes."},{"key":"1166_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11892-008-0057-3","volume":"8","author":"CB Leit\u00e3o","year":"2008","unstructured":"Leit\u00e3o CB, Cure P, Tharvanji T, Baidal DA, Alejandro R. Current challenges in islet transplantation. Curr Diab Rep. 2008;8:324\u201331. \n                      https:\/\/doi.org\/10.1007\/s11892-008-0057-3\n                      \n                    .","journal-title":"Curr Diab Rep"},{"key":"1166_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1590\/2359-3997000000030","volume":"59","author":"J Rheinheimer","year":"2015","unstructured":"Rheinheimer J, Bauer AC, Silveiro SP, Estivalet AAF, Bou\u00e7as AP, Rosa AR, et al. Human pancreatic islet transplantation: an update and description of the establishment of a pancreatic islet isolation laboratory. Arch Endocrinol Metab. 2015;59:161\u201370. \n                      https:\/\/doi.org\/10.1590\/2359-3997000000030\n                      \n                    .","journal-title":"Arch Endocrinol Metab"},{"key":"1166_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2337\/diab.16.1.35","volume":"16","author":"PE Lacy","year":"1967","unstructured":"Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 1967;16:35\u20139. \n                      https:\/\/doi.org\/10.2337\/diab.16.1.35\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2337\/diabetes.50.3.489","volume":"50","author":"PO Carlsson","year":"2001","unstructured":"Carlsson PO, Palm F, Andersson A, Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes. 2001;50:489\u201395. \n                      https:\/\/doi.org\/10.2337\/diabetes.50.3.489\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","volume":"48","author":"W Bennet","year":"1999","unstructured":"Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 1999;48:1907\u201314. \n                      https:\/\/doi.org\/10.2337\/diabetes.48.10.1907\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(02)12020-4","volume":"360","author":"L Moberg","year":"2002","unstructured":"Moberg L, Johansson H, Lukinius A, Berne C, Foss A, K\u00e4llen R, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039\u201345. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(02)12020-4\n                      \n                    .","journal-title":"Lancet."},{"key":"1166_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1399-3089.2007.00419.x","volume":"14","author":"DJ Van Der Windt","year":"2007","unstructured":"Van Der Windt DJ, Bottino R, Casu A, Campanile N, Cooper DKC. Rapid loss of intraportally transplanted islets: an overview of pathophysiology and preventive strategies. Xenotransplantation. 2007;14:288\u201397. \n                      https:\/\/doi.org\/10.1111\/j.1399-3089.2007.00419.x\n                      \n                    .","journal-title":"Xenotransplantation."},{"key":"1166_CR27","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11892-011-0216-9","volume":"11","author":"E Cantarelli","year":"2011","unstructured":"Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep. 2011;11:364\u201374. \n                      https:\/\/doi.org\/10.1007\/s11892-011-0216-9\n                      \n                    .","journal-title":"Curr Diab Rep"},{"key":"1166_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1517\/03009734000000059","volume":"105","author":"W Bennet","year":"2000","unstructured":"Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci. 2000;105:125\u201333. \n                      https:\/\/doi.org\/10.1517\/03009734000000059\n                      \n                    .","journal-title":"Ups J Med Sci"},{"key":"1166_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0168-8227(86)80006-7","volume":"2","author":"RN Margolis","year":"1986","unstructured":"Margolis RN, Holup JJ, Selawry HP. Effects of intratesticular islet transplantation on hepatic glycogen metabolism in the rat. Diabetes Res Clin Pract. 1986;2:291\u20139. \n                      https:\/\/doi.org\/10.1016\/S0168-8227(86)80006-7\n                      \n                    .","journal-title":"Diabetes Res Clin Pract"},{"key":"1166_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/096368979400300606","volume":"3","author":"A Ar\u2019Rajab","year":"2017","unstructured":"Ar\u2019Rajab A, Dawidson IJ, Harris RB, Sentementes JT. Immune privilege of the testis for islet xenotransplantation (rat to mouse). Cell Transplant. 2017;3:493\u20138. \n                      https:\/\/doi.org\/10.1177\/096368979400300606\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/BF00461694","volume":"9","author":"CB Kemp","year":"1973","unstructured":"Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia. 1973;9:486\u201391. \n                      https:\/\/doi.org\/10.1007\/BF00461694\n                      \n                    .","journal-title":"Diabetologia."},{"key":"1166_CR32","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3727\/096368908787648146","volume":"17","author":"R Melzi","year":"2008","unstructured":"Melzi R, Sanvito F, Mercalli A, Andralojc K, Bonifacio E, Piemonti L. Intrahepatic islet transplant in the mouse: functional and morphological characterization. Cell Transplant. 2008;17:1361\u201370. \n                      https:\/\/doi.org\/10.3727\/096368908787648146\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR33","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.biomaterials.2008.12.030","volume":"30","author":"G Mao","year":"2009","unstructured":"Mao G, Chen G, Bai H, Song T, Wang Y. The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells. Biomaterials. 2009;30:1706\u201314. \n                      https:\/\/doi.org\/10.1016\/j.biomaterials.2008.12.030\n                      \n                    .","journal-title":"Biomaterials."},{"key":"1166_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00125-001-0729-x","volume":"45","author":"P De Vos","year":"2002","unstructured":"De Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia. 2002;45:159\u201373. \n                      https:\/\/doi.org\/10.1007\/s00125-001-0729-x\n                      \n                    .","journal-title":"Diabetologia."},{"key":"1166_CR35","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1089\/ten.tea.2008.0118","volume":"15","author":"AG Mallett","year":"2009","unstructured":"Mallett AG, Korbutt GS. Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng Part A. 2009;15:1301\u20139. \n                      https:\/\/doi.org\/10.1089\/ten.tea.2008.0118\n                      \n                    .","journal-title":"Tissue Eng Part A"},{"key":"1166_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrd.2016.232","volume":"16","author":"T Desai","year":"2017","unstructured":"Desai T, Shea LD. Advances in islet encapsulation technologies. Nat Rev Drug Discov. 2017;16:338\u201350. \n                      https:\/\/doi.org\/10.1038\/nrd.2016.232\n                      \n                    .","journal-title":"Nat Rev Drug Discov"},{"key":"1166_CR37","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/ten.TEA.2009.0286","volume":"16","author":"S V\u00e9riter","year":"2010","unstructured":"V\u00e9riter S, Mergen J, Goebbels R-M, Aouassar N, Gr\u00e9goire C, Jordan B, et al. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A. 2010;16:1503\u201313. \n                      https:\/\/doi.org\/10.1089\/ten.TEA.2009.0286\n                      \n                    .","journal-title":"Tissue Eng Part A"},{"key":"1166_CR38","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2337\/diab.40.11.1511","volume":"40","author":"ZP Lum","year":"1991","unstructured":"Lum ZP, Tai IT, Krestow M, Norton J, Vacek I, Sun AM. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes. 1991;40:1511\u20136. \n                      https:\/\/doi.org\/10.2337\/diab.40.11.1511\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR39","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.transproceed.2004.04.059","volume":"36","author":"W Cui","year":"2004","unstructured":"Cui W, Barr G, Faucher KM, Sun X-L, Safley SA, Weber CJ, et al. A membrane-mimetic barrier for islet encapsulation. Transplant Proc. 2004;36:1206\u20138. \n                      https:\/\/doi.org\/10.1016\/j.transproceed.2004.04.059\n                      \n                    .","journal-title":"Transplant Proc"},{"key":"1166_CR40","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.transproceed.2011.10.028","volume":"43","author":"M Lamb","year":"2011","unstructured":"Lamb M, Storrs R, Li S, Liang O, Laugenour K, Dorian R, et al. Function and viability of human islets encapsulated in alginate sheets: in vitro and in vivo culture. Transplant Proc. 2011;43:3265\u20136. \n                      https:\/\/doi.org\/10.1016\/j.transproceed.2011.10.028\n                      \n                    .","journal-title":"Transplant Proc"},{"key":"1166_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00125-011-2431-y","volume":"55","author":"ZL Zhi","year":"2012","unstructured":"Zhi ZL, Kerby A, King AJF, Jones PM, Pickup JC. Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia. 2012;55:1081\u201390. \n                      https:\/\/doi.org\/10.1007\/s00125-011-2431-y\n                      \n                    .","journal-title":"Diabetologia."},{"key":"1166_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/adhm.201200341","volume":"2","author":"M Ma","year":"2013","unstructured":"Ma M, Chiu A, Sahay G, Doloff JC, Dholakia N, Thakrar R, et al. Core-shell hydrogel microcapsules for improved islets encapsulation. Adv Healthc Mater. 2013;2:667\u201372. \n                      https:\/\/doi.org\/10.1002\/adhm.201200341\n                      \n                    .","journal-title":"Adv Healthc Mater"},{"key":"1166_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2310\/6650.2001.33722","volume":"49","author":"HA Hobbs","year":"2001","unstructured":"Hobbs HA, Kendall WF, Darrabie M, Opara EC. Prevention of morphological changes in alginate microcapsules for islet xenotransplantation. J Investig Med. 2001;49:572\u20135. \n                      https:\/\/doi.org\/10.2310\/6650.2001.33722\n                      \n                    .","journal-title":"J Investig Med"},{"key":"1166_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00007890-199703270-00006","volume":"63","author":"P De Vos","year":"1997","unstructured":"De Vos P, Hillebrands JL, De Haan BJ, Strubbe JH, Van Schilfgaarde R. Efficacy of a prevascularized expanded polytetrafluoroethylene solid support system as a transplantation site for pancreatic islets. Transplantation. 1997;63:824\u201330. \n                      https:\/\/doi.org\/10.1097\/00007890-199703270-00006\n                      \n                    .","journal-title":"Transplantation."},{"key":"1166_CR45","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/ten.2005.11.1323","volume":"11","author":"JM Dufour","year":"2005","unstructured":"Dufour JM, Rajotte RV, Zimmerman M, Rezania A, Kin T, Dixon DE, et al. Development of an ectopic site for islet transplantation, using biodegradable scaffolds. Tissue Eng. 2005;11:1323\u201331. \n                      https:\/\/doi.org\/10.1089\/ten.2005.11.1323\n                      \n                    .","journal-title":"Tissue Eng"},{"key":"1166_CR46","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1677\/joe.0.1630181","volume":"163","author":"RN Wang","year":"1999","unstructured":"Wang RN, Rosenberg L. Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. J Endocrinol. 1999;163:181\u201390. \n                      https:\/\/doi.org\/10.1677\/joe.0.1630181\n                      \n                    .","journal-title":"J Endocrinol"},{"key":"1166_CR47","doi-asserted-by":"publisher","first-page":"9677","DOI":"10.1016\/j.biomaterials.2011.08.084","volume":"32","author":"RF Gibly","year":"2011","unstructured":"Gibly RF, Zhang X, Graham ML, Hering BJ, Kaufman DB, Lowe WL, et al. Extrahepatic islet transplantation with microporous polymer scaffolds in syngeneic mouse and allogeneic porcine models. Biomaterials. 2011;32:9677\u201384. \n                      https:\/\/doi.org\/10.1016\/j.biomaterials.2011.08.084\n                      \n                    .","journal-title":"Biomaterials."},{"key":"1166_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1600-6143.2008.02489.x","volume":"9","author":"DM Berman","year":"2009","unstructured":"Berman DM, O\u2019Neil JJ, Coffey LCK, Chaffanjon PCJ, Kenyon NM, Ruiz P, et al. Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold. Am J Transplant. 2009;9:91\u2013104. \n                      https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02489.x\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"1166_CR49","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/01.tp.0000231708.19937.21","volume":"82","author":"H Blomeier","year":"2006","unstructured":"Blomeier H, Zhang X, Rives C, Brissova M, Hughes E, Baker M, et al. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation. Transplantation. 2006;82:452\u20139. \n                      https:\/\/doi.org\/10.1097\/01.tp.0000231708.19937.21\n                      \n                    .","journal-title":"Transplantation."},{"key":"1166_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nbt.2958","volume":"32","author":"SV Murphy","year":"2014","unstructured":"Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol. 2014;32:773\u201385. \n                      https:\/\/doi.org\/10.1038\/nbt.2958\n                      \n                    .","journal-title":"Nat Biotechnol"},{"key":"1166_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bjophthalmol-2013-304446","volume":"98","author":"C Schubert","year":"2014","unstructured":"Schubert C, van Langeveld MC, Donoso LA. Innovations in 3D printing: a 3D overview from optics to organs. Br J Ophthalmol. 2014;98:159\u201361. \n                      https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304446\n                      \n                    .","journal-title":"Br J Ophthalmol"},{"key":"1166_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.rcim.2013.10.005","volume":"30","author":"IT Ozbolat","year":"2014","unstructured":"Ozbolat IT, Chen H, Yu Y. Development of \u2018multi-arm bioprinter\u2019 for hybrid biofabrication of tissue engineering constructs. Robot Comput Integr Manuf. 2014;30:295\u2013304. \n                      https:\/\/doi.org\/10.1016\/j.rcim.2013.10.005\n                      \n                    .","journal-title":"Robot Comput Integr Manuf"},{"key":"1166_CR53","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1002\/adma.201305506","volume":"26","author":"DB Kolesky","year":"2014","unstructured":"Kolesky DB, Truby RL, Gladman AS, Busbee TA, Homan KA, Lewis JA. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater. 2014;26:3124\u201330. \n                      https:\/\/doi.org\/10.1002\/adma.201305506\n                      \n                    .","journal-title":"Adv Mater"},{"key":"1166_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2014.04.007","volume":"184","author":"MT Poldervaart","year":"2014","unstructured":"Poldervaart MT, Gremmels H, van Deventer K, Fledderus JO, Oner FC, Verhaar MC, et al. Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture. J Control Release. 2014;184:58\u201366. \n                      https:\/\/doi.org\/10.1016\/j.jconrel.2014.04.007\n                      \n                    .","journal-title":"J Control Release"},{"key":"1166_CR55","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MOT.0000000000000346","volume":"21","author":"Z Yue","year":"2016","unstructured":"Yue Z, Liu X, Coates PT, Wallace GG. Advances in printing biomaterials and living cells. Curr Opin Organ Transplant. 2016;21:467\u201375. \n                      https:\/\/doi.org\/10.1097\/MOT.0000000000000346\n                      \n                    .","journal-title":"Curr Opin Organ Transplant"},{"key":"1166_CR56","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/term.2476","volume":"12","author":"C Di Bella","year":"2018","unstructured":"Di Bella C, Duchi S, O\u2019Connell CD, Blanchard R, Augustine C, Yue Z, et al. In situ handheld three-dimensional bioprinting for cartilage regeneration. J Tissue Eng Regen Med. 2018;12:611\u201321. \n                      https:\/\/doi.org\/10.1002\/term.2476\n                      \n                    .","journal-title":"J Tissue Eng Regen Med"},{"key":"1166_CR57","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1002\/adfm.201503423","volume":"25","author":"M Kesti","year":"2015","unstructured":"Kesti M, Eberhardt C, Pagliccia G, Kenkel D, Grande D, Boss A, et al. Bioprinting complex cartilaginous structures with clinically compliant biomaterials. Adv Funct Mater. 2015;25:7406\u201317. \n                      https:\/\/doi.org\/10.1002\/adfm.201503423\n                      \n                    .","journal-title":"Adv Funct Mater"},{"key":"1166_CR58","doi-asserted-by":"publisher","first-page":"015007","DOI":"10.1088\/1758-5090\/7\/2\/025009","volume":"8","author":"JW Lee","year":"2016","unstructured":"Lee JW, Choi Y-J, Yong W-J, Pati F, Shim J-H, Kang KS, et al. Development of a 3D cell printed construct considering angiogenesis for liver tissue engineering. Biofabrication. 2016;8:015007. \n                      https:\/\/doi.org\/10.1088\/1758-5090\/7\/2\/025009\n                      \n                    .","journal-title":"Biofabrication."},{"key":"1166_CR59","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/adhm.201600095","volume":"5","author":"Q Gu","year":"2016","unstructured":"Gu Q, Tomaskovic-crook E, Lozano R, Chen Y, Kapsa RM, Zhou Q, et al. Functional 3D neural mini-tissues from printed gel-based bioink and human neural stem cells. Adv Healthc Mater. 2016;5:1429\u201338. \n                      https:\/\/doi.org\/10.1002\/adhm.201600095\n                      \n                    .","journal-title":"Adv Healthc Mater"},{"key":"1166_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bioactmat.2017.11.008","volume":"3","author":"S Derakhshanfar","year":"2018","unstructured":"Derakhshanfar S, Mbeleck R, Xu K, Zhang X, Zhong W, Xing M. 3D bioprinting for biomedical devices and tissue engineering: a review of recent trends and advances. Bioact Mater Elsevier Ltd. 2018;3:144\u201356. \n                      https:\/\/doi.org\/10.1016\/j.bioactmat.2017.11.008\n                      \n                    .","journal-title":"Bioact Mater Elsevier Ltd"},{"key":"1166_CR61","doi-asserted-by":"publisher","first-page":"025009","DOI":"10.1088\/1758-5090\/7\/2\/025009","volume":"7","author":"G Marchioli","year":"2015","unstructured":"\u2022\u2022 Marchioli G, Van Gurp L, Van Krieken PP, Stamatialis D, Engelse M, Van Blitterswijk CA, et al. Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation. Biofabrication. 2015;7:025009. \n                      https:\/\/doi.org\/10.1088\/1758-5090\/7\/2\/025009\n                      \n                     3D bioprinting technology was used to print pancreatic islets using alginate-based bioinks. 3D bioprinted human islets were highly viable and morphologically sound.","journal-title":"Biofabrication."},{"key":"1166_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.201801631","volume":"1801631","author":"S Duin","year":"2019","unstructured":"\u2022\u2022 Duin S, Sch\u00fctz K, Ahlfeld T, Lehmann S, Lode A, Ludwig B, et al. 3D bioprinting of functional islets of Langerhans in an alginate\/methylcellulose hydrogel blend. Adv Healthc Mater. 2019;1801631:1\u201314. \n                      https:\/\/doi.org\/10.1002\/adhm.201801631\n                      \n                     3D bioprinting technology was used to print rat islets using an alginate\/methylcellulose bioink with minimal impact on islet viability\n                              , morphology, and function.","journal-title":"Adv Healthc Mater"},{"key":"1166_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/isl.3.3.15392","volume":"3","author":"D Penko","year":"2011","unstructured":"Penko D, Mohanasundaram D, Sen S, Mee C, Bonder CS, Coates PTH, et al. Incorporation of endothelial progenitor cells into mosaic pseudoislets. Islets. 2011;3:73\u20139. \n                      https:\/\/doi.org\/10.4161\/isl.3.3.15392\n                      \n                    .","journal-title":"Islets."},{"issue":"7","key":"1166_CR64","doi-asserted-by":"publisher","first-page":"e1801181","DOI":"10.1002\/adhm.201801181","volume":"8","author":"X Liu","year":"2019","unstructured":"\u2022\u2022 Liu X, Carter SSD, Renes MJ, Kim J, Rojas-Canales DM, Penko D, et al. Development of a coaxial 3D printing platform for biofabrication of implantable islet-containing constructs. Adv Healthc Mater. 2019;8(7):e1801181. \n                      https:\/\/doi.org\/10.1002\/adhm.201801181\n                      \n                     A co-axial bioprinter was developed in-house and alginate-gelatin methacryloyl bioink was formulated, for co-printing of islets with supporting cells such as endothelial progenitor cells and regulatory T cells. Co-printed mouse islets and endothelial progenitor cells were highly viable.","journal-title":"Adv Healthc Mater"},{"key":"1166_CR65","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.1152\/ajpendo.1985.249.1.E43","volume":"249","author":"N Lifson","year":"1985","unstructured":"Lifson N, Lassa CV, Dixit PK. Relation between blood flow and morphology in islet organ of rat pancreas. Am J Phys. 1985;249:E43\u20138. \n                      https:\/\/doi.org\/10.1152\/ajpendo.1985.249.1.E43\n                      \n                    .","journal-title":"Am J Phys"},{"key":"1166_CR66","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s00125-009-1485-6","volume":"52","author":"A Johansson","year":"2009","unstructured":"Johansson A, Lau J, Sandberg M, Borg LAH, Magnusson PU, Carlsson P-O. Endothelial cell signalling supports pancreatic beta cell function in the rat. Diabetologia. 2009;52:2385\u201394. \n                      https:\/\/doi.org\/10.1007\/s00125-009-1485-6\n                      \n                    .","journal-title":"Diabetologia."},{"key":"1166_CR67","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2337\/diabetes.45.9.1161","volume":"45","author":"AM Davalli","year":"1996","unstructured":"Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes. 1996;45:1161\u20137. \n                      https:\/\/doi.org\/10.2337\/diabetes.45.9.1161\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR68","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3727\/000000003771000219","volume":"12","author":"M de Groot","year":"2003","unstructured":"de Groot M, Schuurs T, Fekken S, Leuvenink H, van Schilfgaarde R, Keizer J. Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplant. 2003;12:867\u201375. \n                      https:\/\/doi.org\/10.3727\/000000003771000219\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR69","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3727\/096368911X566262","volume":"21","author":"PD Campbell","year":"2012","unstructured":"Campbell PD, Weinberg A, Chee J, Mariana L, Ayala R, Hawthorne WJ, et al. Expression of pro- and antiapoptotic molecules of the Bcl-2 family in human islets postisolation. Cell Transplant. 2012;21:49\u201360. \n                      https:\/\/doi.org\/10.3727\/096368911X566262\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR70","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3727\/096368912X658728","volume":"22","author":"J Cantley","year":"2013","unstructured":"Cantley J, Walters SN, Jung M, Weinberg A, Cowley MJ, Whitworth PT, et al. A preexistent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis. Cell Transplant. 2013;22:2147\u201359. \n                      https:\/\/doi.org\/10.3727\/096368912X658728\n                      \n                    .","journal-title":"Cell Transplant"},{"key":"1166_CR71","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00007890-199507000-00002","volume":"60","author":"P Vajkoczy","year":"1995","unstructured":"Vajkoczy P, Menger MD, Simpson E, Messmer K. Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation. 1995;60:123\u20137. \n                      https:\/\/doi.org\/10.1097\/00007890-199507000-00002\n                      \n                    .","journal-title":"Transplantation."},{"key":"1166_CR72","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.2337\/diabetes.51.5.1362","volume":"51","author":"G Mattsson","year":"2002","unstructured":"Mattsson G, Jansson L, Carlsson P-O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes. 2002;51:1362\u20136. \n                      https:\/\/doi.org\/10.2337\/diabetes.51.5.1362\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR73","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1084\/jem.20070166","volume":"204","author":"H-J Cho","year":"2007","unstructured":"Cho H-J, Lee N, Lee JY, Choi YJ, Ii M, Wecker A, et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med. 2007;204:3257\u201369. \n                      https:\/\/doi.org\/10.1084\/jem.20070166\n                      \n                    .","journal-title":"J Exp Med"},{"key":"1166_CR74","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nm0603-702","volume":"9","author":"S Rafii","year":"2003","unstructured":"Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med. 2003;9:702\u201312. \n                      https:\/\/doi.org\/10.1038\/nm0603-702\n                      \n                    .","journal-title":"Nat Med"},{"key":"1166_CR75","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2337\/db13-0617","volume":"63","author":"HS Peiris","year":"2014","unstructured":"Peiris HS, Bonder CS, Coates PT, Keating DJ, Jessup CF. The b-cell\/EC axis: how do islet cells talk to each other? Diabetes Care. 2014;63:3\u201311. \n                      https:\/\/doi.org\/10.2337\/db13-0617\n                      \n                    .","journal-title":"Diabetes Care"},{"key":"1166_CR76","doi-asserted-by":"publisher","first-page":"866","DOI":"10.2337\/db10-1492","volume":"61","author":"S Kang","year":"2012","unstructured":"Kang S, Park HS, Jo A, Hong SH, Lee HN, Lee YY, et al. Endothelial progenitor cell cotransplantation enhances islet engraftment by rapid revascularization. Diabetes. 2012;61:866\u201376. \n                      https:\/\/doi.org\/10.2337\/db10-1492\n                      \n                    .","journal-title":"Diabetes."},{"key":"1166_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0094783","volume":"9","author":"P Quaranta","year":"2014","unstructured":"Quaranta P, Antonini S, Spiga S, Mazzanti B, Curcio M, Mulas G, et al. Co-transplantation of endothelial progenitor cells and pancreatic islets to induce long-lasting normoglycemia in streptozotocin-treated diabetic rats. PLoS One. 2014;9:1\u201313. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0094783\n                      \n                    .","journal-title":"PLoS One"},{"key":"1166_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3727\/096368913X673423","volume":"24","author":"D Penko","year":"2015","unstructured":"\u2022 Penko D, Rojas-Canales D, Mohanasundaram D, Peiris HS, Sun WY, Drogemuller CJ, et al. Endothelial progenitor cells enhance islet engraftment, influence beta cell function and modulate islet connexin 36 expression. Cell Transplant. 2015;24:37\u201348. \n                      https:\/\/doi.org\/10.3727\/096368913X673423\n                      \n                     Co-transplantation of endothelial progenitor cells with pancreatic islets enhanced islet engraftment by improving the cure rate and the glucose control.","journal-title":"Cell Transplant"},{"key":"1166_CR79","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(98)07493-5","volume":"68","author":"D Golshayan","year":"2008","unstructured":"Golshayan D, Pascual M. Tolerance-inducing immunosuppressive strategies in clinical transplantation. Drugs. 2008;68:2113\u201330. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(98)07493-5\n                      \n                    .","journal-title":"Drugs."},{"key":"1166_CR80","unstructured":"Xing Y, Hogquist KA. T-cell tolerance: central and peripheral. Cold Spring Harb Perspect Biol 2012;1\u201316."},{"key":"1166_CR81","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490\u2013500. \n                      https:\/\/doi.org\/10.1038\/nri2785\n                      \n                    .","journal-title":"Nat Rev Immunol"},{"key":"1166_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a015552","volume":"3","author":"Q Tang","year":"2013","unstructured":"Tang Q, Bluestone JA. Regulatory T-cell therapy in transplantation: moving to the clinic. Cold Spring Harb Perspect Med. 2013;3:1\u201315. \n                      https:\/\/doi.org\/10.1101\/cshperspect.a015552\n                      \n                    .","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1166_CR83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523\u201332. \n                      https:\/\/doi.org\/10.1038\/nri2343\n                      \n                    .","journal-title":"Nat Rev Immunol"},{"key":"1166_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/419692","volume":"2013","author":"EC Cunningham","year":"2013","unstructured":"Cunningham EC, Sharland AF, Alex Bishop G. Liver transplant tolerance and its application to the clinic: can we exploit the high dose effect? Clin Dev Immunol. 2013;2013:1\u20139. \n                      https:\/\/doi.org\/10.1155\/2013\/419692\n                      \n                    .","journal-title":"Clin Dev Immunol"},{"key":"1166_CR85","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1432-2277.2011.01260.x","volume":"24","author":"PE Cipp\u00e0","year":"2011","unstructured":"Cipp\u00e0 PE, Fehr T. Spontaneous tolerance in kidney transplantation - an instructive, but very rare paradigm. Transpl Int. 2011;24:534\u20135. \n                      https:\/\/doi.org\/10.1111\/j.1432-2277.2011.01260.x\n                      \n                    .","journal-title":"Transpl Int"},{"key":"1166_CR86","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nbt.3121.ChIP-nexus","volume":"252","author":"G Orlando","year":"2010","unstructured":"Orlando G, Hematti P, Stratta R, Burke G, Di Cocco P, Pisani F, et al. Clinical operational tolerance after renal transplantation. Ann Surg. 2010;252:915\u201328. \n                      https:\/\/doi.org\/10.1038\/nbt.3121.ChIP-nexus\n                      \n                    .","journal-title":"Ann Surg"},{"key":"1166_CR87","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1600-6143.2008.02300.x","volume":"8","author":"W Li","year":"2008","unstructured":"Li W, Kuhr CS, Zheng XX, Carper K, Thomson AW, Reyes JD, et al. New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant. 2008;8:1639\u201351. \n                      https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02300.x\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"1166_CR88","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1517\/17530059.2012.680019.BIOMARKERS","volume":"6","author":"S Heidt","year":"2012","unstructured":"Heidt S, Wood KJ. Biomarkers of operational tolerance in solid organ transplantation. Expert Opin Med Diagn. 2012;6:281\u201393. \n                      https:\/\/doi.org\/10.1517\/17530059.2012.680019.BIOMARKERS\n                      \n                    .","journal-title":"Expert Opin Med Diagn"},{"key":"1166_CR89","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40472-015-0066-5","volume":"2","author":"N Niemann","year":"2015","unstructured":"Niemann N, Sawitzki B. Treg therapy in transplantation: how and when will we do it ? Curr Transplant Reports. 2015;2:233\u201341. \n                      https:\/\/doi.org\/10.1007\/s40472-015-0066-5\n                      \n                    .","journal-title":"Curr Transplant Reports"},{"key":"1166_CR90","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006.Human","volume":"30","author":"JL Riley","year":"2010","unstructured":"Riley JL, June CH, Blazar BR. Human T regulatory cells as therapeutic agents: take a billion or so of these and call me in the morning. Immunity. 2010;30:656\u201365. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2009.04.006.Human\n                      \n                    .","journal-title":"Immunity."},{"key":"1166_CR91","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.smim.2011.04.001","volume":"23","author":"AN McMurchy","year":"2011","unstructured":"McMurchy AN, Bushell A, Levings MK, Wood KJ. Moving to tolerance: clinical application of T regulatory cells. Semin Immunol. 2011;23:304\u201313. \n                      https:\/\/doi.org\/10.1016\/j.smim.2011.04.001\n                      \n                    .","journal-title":"Semin Immunol"},{"key":"1166_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0090387","volume":"9","author":"F Xiao","year":"2014","unstructured":"Xiao F, Ma L, Zhao M, Huang G, Mirenda V, Dorling A, et al. Ex vivo expanded human regulatory T cells delay islet allograft rejection via inhibiting islet-derived monocyte chemoattractant protein-1 production in CD34+ stem cells-reconstituted NOD-scid IL2rgnull mice. PLoS One. 2014;9:1\u201312. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0090387\n                      \n                    .","journal-title":"PLoS One"},{"key":"1166_CR93","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/TP.0b013e31829fa271","volume":"96","author":"DC Wu","year":"2013","unstructured":"Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, et al. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model. Transplantation. 2013;96:707\u201316. \n                      https:\/\/doi.org\/10.1097\/TP.0b013e31829fa271\n                      \n                    .","journal-title":"Transplantation."},{"key":"1166_CR94","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","volume":"17","author":"S Chandran","year":"2017","unstructured":"\u2022 Chandran S, Tang Q, Sarwal M, Polyclonal Regulatory T. Cell therapy for control of inflammation in kidney transplants. Am J Transplant. 2017;17:2945\u201354. \n                      https:\/\/doi.org\/10.1111\/ajt.14415\n                      \n                     Infusion of ex vivo expanded regulatory T cells was well tolerated with no adverse effects in kidney transplant recipients.","journal-title":"Am J Transplant"},{"key":"1166_CR95","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.28459","volume":"64","author":"S Todo","year":"2016","unstructured":"\u2022 Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A, Oura T, et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology. 2016;64:632\u201343. \n                      https:\/\/doi.org\/10.1002\/hep.28459\n                      \n                     Infusion of ex vivo expanded regulatory T cells was well tolerated with no adverse effects in liver transplant recipients. Seven patients have been maintaining normal graft function without the use of immunosuppressive drugs for more than 16\u00a0months.","journal-title":"Hepatology."},{"key":"1166_CR96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1677\/JME-06-0053","volume":"38","author":"AM Ackermann","year":"2007","unstructured":"Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol. 2007;38:193\u2013206. \n                      https:\/\/doi.org\/10.1677\/JME-06-0053\n                      \n                    .","journal-title":"J Mol Endocrinol"},{"key":"1166_CR97","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1530\/JOE-13-0557","volume":"221","author":"A Hughes","year":"2014","unstructured":"Hughes A, Rojas-canales D, Drogemuller C. IGF2: an endocrine hormone to improve islet transplant survival. J Endocrinol. 2014;221:R41\u20138. \n                      https:\/\/doi.org\/10.1530\/JOE-13-0557\n                      \n                    .","journal-title":"J Endocrinol"},{"key":"1166_CR98","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/39797","volume":"389","author":"W Reik","year":"1997","unstructured":"Reik W, Sun F-L, Dean WL, Kelsey G, Allen ND. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature. 1997;389:809\u201315. \n                      https:\/\/doi.org\/10.1038\/39797\n                      \n                    .","journal-title":"Nature."},{"key":"1166_CR99","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1210\/endo.139.6.6042","volume":"139","author":"J Petrik","year":"1998","unstructured":"Petrik J, Arany E, McDonald TJ, Hill DJ. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 1998;139:2994\u20133004. \n                      https:\/\/doi.org\/10.1210\/endo.139.6.6042\n                      \n                    .","journal-title":"Endocrinology."},{"key":"1166_CR100","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1210\/endo.141.3.7354","volume":"141","author":"DJ Hill","year":"2000","unstructured":"Hill DJ, Strutt B, Arany E, Zaina S, Coukell S, Graham CF. Increased and persistent circulating insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets. Endocrinology. 2000;141:1151\u20137. \n                      https:\/\/doi.org\/10.1210\/endo.141.3.7354\n                      \n                    .","journal-title":"Endocrinology."},{"key":"1166_CR101","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1677\/joe.0.1380401","volume":"138","author":"J Hogg","year":"1993","unstructured":"Hogg J, Han VK, Clemmons DR, Hill DJ. Interactions of nutrients, insulin-like growth factors (IGFs) and IGF-binding proteins in the regulation of DNA synthesis by isolated fetal rat islets of Langerhans. J Endocrinol. 1993;138:401\u201312. \n                      https:\/\/doi.org\/10.1677\/joe.0.1380401\n                      \n                    .","journal-title":"J Endocrinol"},{"key":"1166_CR102","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1210\/en.2002-0185","volume":"144","author":"R Robitaille","year":"2003","unstructured":"Robitaille R, Dusseault J, Henley N, Rosenberg L, Hall\u00e9 J-P. Insulin-like growth factor II allows prolonged blood glucose normalization with a reduced islet cell mass transplantation. Endocrinology. 2003;144:3037\u201345. \n                      https:\/\/doi.org\/10.1210\/en.2002-0185\n                      \n                    .","journal-title":"Endocrinology."},{"key":"1166_CR103","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1210\/endo.140.10.7042","volume":"140","author":"J Petrik","year":"1999","unstructured":"Petrik J, Reusens B, Arany E, Remacle C, Coelho C, Hoet JJ, et al. A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinology. 1999;140:4861\u201373. \n                      https:\/\/doi.org\/10.1210\/endo.140.10.7042\n                      \n                    .","journal-title":"Endocrinology."},{"key":"1166_CR104","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/TP.0b013e31827fa453","volume":"95","author":"A Hughes","year":"2013","unstructured":"Hughes A, Mohanasundaram D, Kireta S, Jessup CF, Drogemuller CJ, Coates PTH. Insulin-like growth factor-II (IGF-II) prevents proinflammatory cytokine-induced apoptosis and significantly improves islet survival after transplantation. Transp J. 2013;95:671\u20138. \n                      https:\/\/doi.org\/10.1097\/TP.0b013e31827fa453\n                      \n                    .","journal-title":"Transp J"},{"key":"1166_CR105","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes and Cancer. 2011;2:1097\u2013105. \n                      https:\/\/doi.org\/10.1177\/1947601911423031\n                      \n                    .","journal-title":"Genes and Cancer"},{"key":"1166_CR106","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/S0960-9822(03)00378-6","volume":"13","author":"E Lammert","year":"2003","unstructured":"Lammert E, Gu G, Mclaughlin M, Brown D, Brekken R, Murtaugh LC, et al. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol. 2003;13:1070\u20134. \n                      https:\/\/doi.org\/10.1016\/S0960-9822(03)00378-6\n                      \n                    .","journal-title":"Curr Biol"},{"key":"1166_CR107","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/TP.0b013e3181ba2e87","volume":"88","author":"P Witkowski","year":"2009","unstructured":"Witkowski P, Sondermeijer H, Hardy MA, Woodland DC, Lee K, Bhagat G, et al. Islet grafting and imaging in a bioengineered intramuscular space. Transplantation. 2009;88:1065\u201374. \n                      https:\/\/doi.org\/10.1097\/TP.0b013e3181ba2e87\n                      \n                    .","journal-title":"Transplantation."},{"key":"1166_CR108","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/adhm.201600058","volume":"5","author":"G Marchioli","year":"2016","unstructured":"\u2022 Marchioli G, Di Luca A, De Koning E, Engelse M, Van Blitterswijk CA, Karperien M, et al. Hybrid polycaprolactone\/alginate scaffolds functionalized with VEGF to promote de novo vessel formation for the transplantation of islets of Langerhans. Adv Healthc Mater. 2016;5:1606\u201316. \n                      https:\/\/doi.org\/10.1002\/adhm.201600058\n                      \n                     Polycaprolactone scaffold functionalized with VEGF promoted vascularization and improved function of encapsulated islets embedded within the polycaprolactone scaffold.","journal-title":"Adv Healthc Mater"},{"key":"1166_CR109","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J. The role of interleukin - 2 during homeostasis and activation of the immune system. Nat Rev Immunol. 2012;12:180\u201390. \n                      https:\/\/doi.org\/10.1038\/nri3156\n                      \n                    .","journal-title":"Nat Rev Immunol"},{"key":"1166_CR110","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1084\/jem.156.6.1577","volume":"156","author":"S Sakaguchi","year":"1982","unstructured":"Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. J Exp Med. 1982;156:1577\u201386.","journal-title":"J Exp Med"},{"key":"1166_CR111","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","volume":"17","author":"T Chinen","year":"2016","unstructured":"Chinen T, Kannan AK, Levine AG, Fan X, Klein U, Zheng Y, et al. An essential role for IL-2 receptor in regulatory T cell function Takatoshi. Nat Immunol. 2016;17:1322\u201333. \n                      https:\/\/doi.org\/10.1038\/ni.3540\n                      \n                    .","journal-title":"Nat Immunol"},{"key":"1166_CR112","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jaci.2009.02.011","volume":"123","author":"S L\u00e9tourneau","year":"2009","unstructured":"L\u00e9tourneau S, Krieg C, Pantaleo G, Boyman O. IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets. J Allergy Clin Immunol. 2009;123:758\u201362. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2009.02.011\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"key":"1166_CR113","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4049\/jimmunol.1000082","volume":"185","author":"TJ Sadlon","year":"2010","unstructured":"Sadlon TJ, Wilkinson BG, Pederson S, Brown CY, Bresatz S, Gargett T, et al. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol. 2010;185:1071\u201381. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1000082\n                      \n                    .","journal-title":"J Immunol"},{"key":"1166_CR114","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/ni.2084","volume":"12","author":"M Beyer","year":"2011","unstructured":"Beyer M, Thabet Y, M\u00fcller R, Sadlon T, Classen S, Lahl K, et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat Immunol. 2011;12:898\u2013907. \n                      https:\/\/doi.org\/10.1038\/ni.2084\n                      \n                    .","journal-title":"Nat Immunol"},{"key":"1166_CR115","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1073\/pnas.1620835114","volume":"114","author":"G Whitehouse","year":"2017","unstructured":"Whitehouse G, Gray E, Mastoridis S, Merritt E, Kodela E, Yang JHM. IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors. Proc Natl Acad Sci USA. 2017;114:7083\u20138. \n                      https:\/\/doi.org\/10.1073\/pnas.1620835114\n                      \n                    .","journal-title":"Proc Natl Acad Sci USA"},{"key":"1166_CR116","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.it.2012.07.007","volume":"33","author":"EM Shevach","year":"2013","unstructured":"Shevach EM. Application of IL-2 therapy to target T regulatory cell function. Trends Immunol. 2013;33:626\u201332. \n                      https:\/\/doi.org\/10.1016\/j.it.2012.07.007\n                      \n                    .","journal-title":"Trends Immunol"},{"key":"1166_CR117","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1182\/blood-2006-02-004747","volume":"108","author":"E Zorn","year":"2006","unstructured":"Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, et al. IL-2 regulates FOXP3 expression in human CD4+ CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. 2006;108:1571\u201380. \n                      https:\/\/doi.org\/10.1182\/blood-2006-02-004747\n                      \n                    .","journal-title":"Blood."},{"key":"1166_CR118","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","volume":"365","author":"J Koreth","year":"2011","unstructured":"Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055\u201366. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1108188\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"1166_CR119","doi-asserted-by":"publisher","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","volume":"5","author":"K Matsuoka","year":"2013","unstructured":"Matsuoka K, Koreth J, Kim HT, Bascug OG, Kawano Y, Murase K, et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Sci Transl Med. 2013;5:179ra43. \n                      https:\/\/doi.org\/10.1126\/scitranslmed.3005265\n                      \n                    .","journal-title":"Sci Transl Med"},{"key":"1166_CR120","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","volume":"128","author":"J Koreth","year":"2016","unstructured":"Koreth J, Kim HT, Jones KT, Lange PB, Reynolds CG, Chammas MJ, et al. Efficacy , durability , and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease. Blood. 2016;128:130\u20138. \n                      https:\/\/doi.org\/10.1182\/blood-2016-02-702852\n                      \n                    .","journal-title":"Blood."}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-019-1166-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-019-1166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:42:25Z","timestamp":1593733345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-019-1166-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":120,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s11892-019-1166-x","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"4 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"53"}}